Evidence map›Paper›PMID 38300418›Full record

ReviewDigestive diseases and sciences2024

A Novel Method of Calculating the Drained Liver Volume Using a 3D Volume Analyzer for Biliary Drainage of Unresectable Malignant Hilar Biliary Obstruction.

Naoto Imagawa, Mitsuharu Fukasawa, Shinichi Takano, Satoshi Kawakami, Yoshimitsu Fukasawa, Hiroyuki Hasegawa, Natsuhiko Kuratomi, Shota Harai, Naruki Shimamura, Dai Yoshimura and 5 more

Abstract readReview
In one paragraph

Review in Digestive diseases and sciences, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Observational
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors.

Naoto ImagawaDepartment of Gastroenterology, University of Yamanashi, Shimokato, Chuo City, 1110, 409-3898, Yamanashi, Japan.
Mitsuharu FukasawaDepartment of Gastroenterology, University of Yamanashi, Shimokato, Chuo City, 1110, 409-3898, Yamanashi, Japan. fmitsu@yamanashi.ac.jp.ORCID http://orcid.org/0000-0003-3137-9685
Shinichi TakanoDepartment of Gastroenterology, University of Yamanashi, Shimokato, Chuo City, 1110, 409-3898, Yamanashi, Japan.
Satoshi KawakamiDepartment of Gastroenterology, University of Yamanashi, Shimokato, Chuo City, 1110, 409-3898, Yamanashi, Japan.
Yoshimitsu FukasawaDepartment of Gastroenterology, University of Yamanashi, Shimokato, Chuo City, 1110, 409-3898, Yamanashi, Japan.
Hiroyuki HasegawaDepartment of Gastroenterology, University of Yamanashi, Shimokato, Chuo City, 1110, 409-3898, Yamanashi, Japan.
Natsuhiko KuratomiDepartment of Gastroenterology, University of Yamanashi, Shimokato, Chuo City, 1110, 409-3898, Yamanashi, Japan.
Shota HaraiDepartment of Gastroenterology, University of Yamanashi, Shimokato, Chuo City, 1110, 409-3898, Yamanashi, Japan.
Naruki ShimamuraDepartment of Gastroenterology, University of Yamanashi, Shimokato, Chuo City, 1110, 409-3898, Yamanashi, Japan.
Dai YoshimuraDepartment of Gastroenterology, University of Yamanashi, Shimokato, Chuo City, 1110, 409-3898, Yamanashi, Japan.
Shoji KobayashiDepartment of Gastroenterology, University of Yamanashi, Shimokato, Chuo City, 1110, 409-3898, Yamanashi, Japan.
Takashi YoshidaDepartment of Gastroenterology, University of Yamanashi, Shimokato, Chuo City, 1110, 409-3898, Yamanashi, Japan.
Mitsuaki SatoDepartment of Gastroenterology, University of Yamanashi, Shimokato, Chuo City, 1110, 409-3898, Yamanashi, Japan.
Yuichiro SuzukiDepartment of Gastroenterology, University of Yamanashi, Shimokato, Chuo City, 1110, 409-3898, Yamanashi, Japan.
Nobuyuki EnomotoDepartment of Gastroenterology, University of Yamanashi, Shimokato, Chuo City, 1110, 409-3898, Yamanashi, Japan.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectivesIn patients with unresectable malignant hilar biliary obstruction (UMHBO), drainage of ≥ 50% liver volume correlates with better clinical outcomes. Accurately measuring the liver volume to be drained by biliary stents is required. We aimed to develop a novel method for calculating the drained liver volume (DLV) using a 3D volume analyzer (3D volumetry), and assess the usefulness for drainage in patients with UMHBO.

methodsThree-dimensional volumetry comprises the following steps: (1) manual tracing of bile duct using 3D imaging system; (2) 3D reconstruction of bile duct and liver parenchyma; and (3) calculating DLV according to the 3D distribution of bile ducts. Using 3D volumetry, we reviewed data of patients who underwent biliary drainage for UMHBO, calculated the DLV, and determined the association between DLV and biliary drainage outcome.

resultsThere were 104 eligible cases. The mean DLV was 708 ± 393 ml (53% ± 21%). and 65 patients (63%) underwent drainage of   ≥50% liver volume. The clinical success rate was significantly higher in patients with DLV ≥ 50% than in patients with DLV < 50% (89% vs. 28%, P < 0.001). The median time to recurrence of biliary obstruction (TRBO) and survival time were significantly longer in patients with DLV ≥ 50% than in patients with DLV < 50% (TRBO, 292 vs. 119 days, P = 0.03; survival, 285 vs. 65days, P = 0.004, log-rank test, respectively).

conclusionsThree-dimensional volumetry, a novel method to calculate DLV accurately according to bile duct distribution was useful for drainage in UMHBO patients.

Indexed as

Bile Duct NeoplasmsCholestasisBile DuctsDrainageHumansLiverStentsTreatment Outcome3D Volume analyzerBiliary drainageHilar biliary obstructionLiver volume

Identifiers

PMID38300418
PMCPMC10960883

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.